Who invested in EndoStim?
EndoStim's investors include Prolog Ventures, Sante Ventures, Billiken Angels Network, Vectis Healthcare & Life Sciences Fund and Vectis Healthcare & Life Sciences Fund II.

United States · Series E startup
Funding summaryUpdated 26 Oct 2026
$45Mraised across 8 rounds since 2009, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $2.5M sold, first sale May 2015
No investor was named in the report.
From a historical funding recordSEC filing: $6.4M sold, first sale Jun 2014
Reported by bizjournals.comSEC filing: $14M sold, first sale Dec 2012
Reported by sec.govSEC filing: $9.1M sold, first sale Dec 2012
No investor was named in the report.
Reported by sec.govSEC filing: $5.5M sold, first sale Nov 2011
Reported by stlouis.bizjournals.comSEC filing: $6.0M sold, first sale Jul 2010
No investor was named in the report.
From a historical funding recordSEC filing: $775K sold, first sale Sept 2009
No investor was named in the report.
From a historical funding recordSEC filing: $550K sold, first sale Jul 2009
From EndoStim's own website: 3 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
EndoStim's investors include Prolog Ventures, Sante Ventures, Billiken Angels Network, Vectis Healthcare & Life Sciences Fund and Vectis Healthcare & Life Sciences Fund II.
EndoStim has raised $45M across 8 rounds since 2009.
EndoStim's most recent round was a Series E of $2.5M in May 2015.
EndoStim's largest round on record is $14M (Series D), in Jun 2013.
EndoStim's first round on record, in Jul 2010, was backed by Sante Ventures and Vectis Healthcare & Life Sciences Fund.
EndoStim's latest named round is a Series E, in May 2015.
EndoStim is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.